Lopinavir/ritonavir as part of schemes of HAARt in HIV-positive pregnant women and women of reproductive age: the dynamics of clinical and immunological and virological indicators

Lopinavir/ritonavir as part of schemes of HAARt in HIV-positive pregnant women and women of reproductive age: the dynamics of clinical and immunological and virological indicators

The paper presents the results of an open randomized comparative study of the clinical, immunological and virological efficacy of regimens of HAART, including lopinavir/ritonavir (LPV/RTV – “Kaletra”, Abbvie) pregnant women (n= 104) women and women of reproductive age (n=50) c HIV infection. The inc...

Full description

Bibliographic Details
Main Authors: A. B. Konkova-Reidman, O. L. Ruhtina, Yu. I. Bulankov
Format: Article
Language:Russian
Published: Journal Infectology 2015-04-01
Series:Журнал инфектологии
Subjects:
hiv infection
female
pregnancy
lopinavir/ritonavir
haart
reproductive age
Online Access:https://journal.niidi.ru/jofin/article/view/375

Similar Items

Similar Items